Pharmaceutical Tablet Supply – Bismuth Subsalicylate (NSN: 6505012448010)

The contract pertains to the supply of FDA-approved bismuth subsalicylate tablets in commercial packaging for distribution through military medical channels, specifically under the National Stock Number 6505012448010. All deliverables must fully comply with federal and military requirements for labeling, packaging, and hazardous materials handling, ensuring seamless integration into the defense logistics system. The product is intended for use in operational and garrison medical settings, and the packaging must meet stringent durability, tamper-evidence, and regulatory standards appropriate for military deployment environments. The solicitation is issued as a subcontract under the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with performance required at Fort Bragg, North Carolina, 28310. The posting date is July 23, 2026, and responses are due by July 29, 2026. The NAICS code 325412 indicates the classification relates to pharmaceutical and medicine manufacturing, aligning the contractor’s capabilities with the production of finished pharmaceutical dosage forms. The procurement is managed through the DLA Troop Support system via the DIBBS platform, and bidders must be prepared to meet all contractual obligations including quality assurance, traceability, and timely delivery to sustain military medical readiness.